Reliable Conjugation Technology for Precision Medicine
  • Home
  • Pipeline
  • The Technology
    • Peptide Asx Ligase (PALs)
    • History
    • Strong Science
  • Management
    • Directors & Cofounders
    • Scientific Advisory Board
    • Executive Scientific Team
  • News
  • Contact us
  • More
    • Home
    • Pipeline
    • The Technology
      • Peptide Asx Ligase (PALs)
      • History
      • Strong Science
    • Management
      • Directors & Cofounders
      • Scientific Advisory Board
      • Executive Scientific Team
    • News
    • Contact us
Reliable Conjugation Technology for Precision Medicine
  • Home
  • Pipeline
  • The Technology
    • Peptide Asx Ligase (PALs)
    • History
    • Strong Science
  • Management
    • Directors & Cofounders
    • Scientific Advisory Board
    • Executive Scientific Team
  • News
  • Contact us

Wee Kiat Tan, Chief Executive Officer

•Previously co-CEO and COO of NASDAQ-listed biotech, which he built from 1 to 30 people

•Led First in-Human Phase I clinical trial

Abbas El Sahili, Chief Technology Officer

•>30 scientific papers, 3 patents

•10 years experience

•Expertise in peptide ligases

•Expertise in protein engineering

Siew Pheng Lim, Chief Scientific Officer

•>16 years industry experience

•>70 scientific papers, 3 patents

•Expertise in cancer biology

•Expertise in drug discovery


Copyright © 2025 Singzyme

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept